The global single-cell sequencing market is expected to reach USD 3,230.6 Million by 2027, according to a new report by Emergen Research. Single-cell sequencing finds widespread use in resolving heterogeneity of tumor, reconstruction of cancer cell evolutionary courses, and identification of rare sub-clones, thereby providing a promising technique for addressing resistance to drugs.

To get leading market solutions, visit the link below:

https://www.emergenresearch.co....m/industry-report/si

The global gene editing Market is projected to reach USD 15.79 billion by 2027, according to a recent report by Emergen Research. The use of the technology for malady wipeout through direct correction of disturbances in traditional physiology, engineering the immunologic response, and alteration of microorganism targets within the host which is anticipated to drive the market with substantial opportunities.

https://www.emergenresearch.co....m/industry-report/ge

Market Size – USD 530.3 million in 2019, Market Growth - CAGR of 4.6%, Market Trends –Growing awareness among patients regarding advanced diagnostic solutions

Key participants include Natus Medical Incorporated, Philips Lighting Holding B.V., GE Healthcare, Atom Medical Corporation, Herbert Waldmann GmbH & Co. KG, Phoenix Medical Systems Pvt. Ltd., Nice Neotech Medical Systems Pvt. Ltd., Solarc Systems Inc., National Biological Corporation, and The Daavlin Company, among others.
To get leading market solutions, visit the link below:

https://www.emergenresearch.co....m/industry-report/ph